ISIN | LU1033754018 |
---|---|
No. de valeur | 23712967 |
Bloomberg Global ID | |
Nom de fond | PROTEA - Sectoral Emerging Markets Healthcare Fund IF USD |
Prestataire de fonds |
Sectoral Asset Management Inc
1010 Sherbrooke St. West, Suite 1610 QC H3A 2R7 Montreal Canada Téléphone: +1 514 849 8777 E-Mail: BusinessDevelopment@sectoral.com |
Prestataire de fonds | Sectoral Asset Management Inc |
Représentant en Suisse |
FundPartner Solutions (Suisse) SA Genève 75 |
Distributeur(s) | |
Classe d'actifs | Fonds en actions |
EFC Catégorie | |
Catégorie de parts | Accumulation |
Pays d'origine | Luxembourg |
Conditions d'émission de parts | Combinaison de commission d'émission en faveur de la direction du fonds et frais de transaction en faveur du fonds |
Conditions de rachat de parts | Combinaison de commission de rachat en faveur de la direction du fonds et frais de transaction en faveur du fonds |
Stratégie d'investissement *** | This Sub-Fund aims to achieve capital growth in USD. While respecting the principle of risk diversification, the Sub-Fund’s net assets are primarily invested in equities, equitylike transferable securities, participation certificates etc. issued by small, mid and large cap companies which are based in an emerging market and/or conduct the majority of their business in an emerging market and are mainly active in the healthcare sector and depositary receipts, such as American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs) and European Depositary Receipts (EDRs), referring to such securities. |
Particularités |
Prix actuel * | 9.90 USD | 01.08.2024 |
---|---|---|
Prix précédent * | 9.97 USD | 31.07.2024 |
Max 52 semaines * | 11.44 USD | 15.11.2023 |
Min 52 semaines * | 9.11 USD | 18.04.2024 |
NAV * | 9.90 USD | 01.08.2024 |
Issue Price * | 9.90 USD | 01.08.2024 |
Redemption Price * | ||
Closing Price * | ||
Prix minimal indicatif | ||
Actifs du fonds *** | 4'012'381 | |
Actifs de la classe *** | 3'276'949 | |
Trading Information SIX |
YTD Performance | -9.59% |
29.12.2023 - 01.08.2024
29.12.2023 01.08.2024 |
---|---|---|
YTD Performance (en CHF) | -6.17% |
29.12.2023 - 01.08.2024
29.12.2023 01.08.2024 |
1 mois | +3.02% |
01.07.2024 - 01.08.2024
01.07.2024 01.08.2024 |
3 mois | +0.10% |
02.05.2024 - 01.08.2024
02.05.2024 01.08.2024 |
6 mois | +1.33% |
01.02.2024 - 01.08.2024
01.02.2024 01.08.2024 |
1 an | -14.95% |
01.08.2023 - 01.08.2024
01.08.2023 01.08.2024 |
2 ans | -17.91% |
01.08.2022 - 01.08.2024
01.08.2022 01.08.2024 |
3 ans | -50.18% |
02.08.2021 - 01.08.2024
02.08.2021 01.08.2024 |
5 ans | +2.27% |
01.08.2019 - 01.08.2024
01.08.2019 01.08.2024 |
Quota de participation de capital en % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Part de la fortune du fonds en % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quota d'immobilier en % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 01.08.2024 |
Celltrion Inc | 6.25% | |
---|---|---|
Samsung BioLogics Co Ltd | 5.66% | |
Apollo Hospitals Enterprise Ltd | 5.48% | |
Dr Reddy's Laboratories Ltd ADR | 5.00% | |
Sun Pharmaceuticals Industries Ltd | 4.84% | |
BeiGene Ltd ADR | 4.32% | |
WuXi Biologics (Cayman) Inc | 4.29% | |
Rede d or Sao Luiz SA Ordinary Shares | 4.24% | |
Bangkok Dusit Medical Services PCL Units Non-Voting Depository Receipt | 3.90% | |
Cipla Ltd | 3.59% | |
Dernière mise à jour des données | 31.12.2023 |
TER | 1.70% |
---|---|
Date TER | 30.06.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.10% |
Ongoing Charges *** | 1.58% |
SRRI ***
|
|
Date SRRI *** | 30.06.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |